|Avg Daily Vol (13 Wks)||257,246|
- Last trade 5/23/2013 4:00 PM ET
|Net Profit Margin||6.16%|
|Market Cap||268.42 Mil|
|Shares Outstanding||54.01 Mil|
- * last 12 months
- Seeking Alpha | 5/19/2013
- SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China MarketMarketwire | 5/16/2013
- Marketwire | 5/16/2013
- Briefing.com | 5/16/2013
- Seeking Alpha | 5/10/2013
- Seeking Alpha | 4/1/2013
- SciClone Pharmaceuticals Management Presents at Lazard Capital Markets Healthcare Conference (Transcript)Seeking Alpha | 11/15/2012
- Seeking Alpha | 11/9/2012
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Quotes delayed 15min, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.